Enzymatica AB ENZY
OMXSTO · İsveç · Sağlık Teknolojisi
SEK 1,74+0,03 (+%1,46)
Piyasa kapalı· · SEK · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Piyasa kapalı· · SEK · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
As European markets navigate the complexities of geopolitical developments and economic shifts, investors are keeping a keen eye on opportunities that may arise. Penny stocks, although an older term, continue to capture attention due to their potential for value and growth in smaller or newer companies. By focusing on those with strong financial foundations, investors can uncover promising prospects that might offer both stability and upside potential.
The European markets have shown a mixed performance, with the pan-European STOXX Europe 600 Index ending the week slightly up amid ongoing geopolitical tensions and economic uncertainties. Amid these broader market conditions, investors often look for opportunities beyond established names, and penny stocks can offer intriguing possibilities. While the term "penny stock" might seem outdated, it still signifies smaller or newer companies that can present unique opportunities. We've identified...
European markets have shown volatility recently, with the pan-European STOXX Europe 600 Index hitting a new high but ending the week broadly unchanged. Amid such fluctuations, investors often seek opportunities that can offer both growth potential and financial resilience. Penny stocks, though an older term, still hold relevance as they often represent smaller or newer companies that could provide affordability and growth potential when backed by strong financials.
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.